InsidersTradesSigma
Follow the RemeGen Co., Ltd. stock price and the full management transaction log of the company, a listed issuer based in Hong Kong. Shares are quoted on the HK market, under the oversight of HKEX. Operating in the Health Care sector, RemeGen Co., Ltd. has published 53 public disclosures. Market capitalisation: €49.6bn. The latest transaction was reported on 24 April 2026 (Sale). Among the most active insiders: Lin Jian. All data is openly available.
53
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€37m
53 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate RemeGen Co., Ltd. Buy (bullish), based on 15 analysts. Average price target: HK$115.63.
4Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 13,059 of 29,064 companies
54.6
score / 100
Value27
Quality82
FCF yld-0.3%
Earn yld1.5%
EV/EBITDA44.8x
ROE45%
Gross mgn87%
Net mgn22%
Debt/EBITDA2.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 April 2026
Declarations53 total
10,000 shares@ HK$90.07251.3% of flowShareXHKGHKEX:DA20260423E00706
20,000 shares@ HK$97.202.9% of flowShareXHKGHKEX:DA20260423E00726
160,000 shares@ HK$89.2521.4% of flowShareXHKGHKEX:DA20260423E00682
53,000 shares@ HK$91.94347.2% of flowShareXHKGHKEX:DA20260423E00764
10,000 shares@ HK$90.07251.3% of flowShareXHKGHKEX:DA20260423E00758
60,000 shares@ HK$103.009.2% of flowShareXHKGHKEX:DA20260423E00759
60,000 shares@ HK$85.007.7% of flowShareXHKGHKEX:DA20260423E00755
20,000 shares@ HK$97.202.9% of flowShareXHKGHKEX:DA20260423E00709
53,000 shares@ HK$91.94347.2% of flowShareXHKGHKEX:DA20260423E00712
60,000 shares@ HK$103.009.2% of flowShareXHKGHKEX:DA20260423E00707
160,000 shares@ HK$89.2521.4% of flowShareXHKGHKEX:DA20260423E00705
60,000 shares@ HK$86.007.7% of flowShareXHKGHKEX:DA20260423E00704
60,000 shares@ HK$85.007.7% of flowShareXHKGHKEX:DA20260423E00703
100,000 shares@ HK$108.49616.0% of flowShareXHKGHKEX:DA20260423E00701
53,000 shares@ HK$91.94347.2% of flowShareXHKGHKEX:DA20260423E00729
160,000 shares@ HK$89.2521.4% of flowShareXHKGHKEX:DA20260423E00722
60,000 shares@ HK$103.009.2% of flowShareXHKGHKEX:DA20260423E00724
25 of 53 declarations
关于 RemeGen Co., Ltd.
荣昌生物制药（烟台）股份有限公司是一家中国生物制药公司，专注于癌症及其他严重疾病治疗的研发。该公司以 H 股代码在香港证券交易所上市。